
EDAP TMS S.A. EDAP
€ 3.18
-2.37%
Quartalsbericht 2024-Q4
hinzugefügt 03.01.2026
EDAP TMS S.A. Langfristige Verbindlichkeiten 2011-2026 | EDAP
Langfristige Verbindlichkeiten Jährlich EDAP TMS S.A.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 7.44 M | 8.22 M | 6.96 M | 5.6 M | 7.13 M | 7.88 M | 4.86 M | 6 M | 9.16 M | 3.14 M |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 9.16 M | 3.14 M | 6.64 M |
Langfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
19.1 M | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | ||
|
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | ||
|
Cognyte Software Ltd.
CGNT
|
1.33 M | $ 9.57 | 0.31 % | $ 687 M | ||
|
Alphatec Holdings
ATEC
|
89.9 M | $ 22.72 | 3.41 % | $ 3.25 B | ||
|
AxoGen
AXGN
|
1.61 M | $ 32.99 | 0.12 % | $ 1.46 B | ||
|
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | ||
|
Apyx Medical Corporation
APYX
|
1.1 M | $ 3.49 | 0.72 % | $ 121 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
1.35 B | $ 316.68 | -2.3 % | $ 8.93 B | ||
|
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
11.8 B | $ 99.0 | 0.36 % | $ 146 B | ||
|
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
1.28 B | $ 52.05 | -1.81 % | $ 7.76 K | ||
|
Abbott Laboratories
ABT
|
25.7 B | $ 126.3 | -0.58 % | $ 220 B | ||
|
CONMED Corporation
CNMD
|
877 M | $ 44.57 | 2.65 % | $ 1.37 B | ||
|
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | ||
|
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
430 M | - | -10.19 % | $ 1.99 M | ||
|
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
161 M | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
8.87 K | $ 28.83 | -1.08 % | $ 244 M | ||
|
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | ||
|
InMode Ltd.
INMD
|
12 M | $ 14.29 | -8.66 % | $ 1.13 B | ||
|
Align Technology
ALGN
|
184 M | $ 170.77 | 2.37 % | $ 12.8 B | ||
|
Accuray Incorporated
ARAY
|
196 M | $ 0.9 | 3.41 % | $ 92.5 M | ||
|
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
23.9 M | $ 15.28 | -0.07 % | $ 413 M | ||
|
FONAR Corporation
FONR
|
36.4 M | $ 18.56 | 0.08 % | $ 122 M | ||
|
Globus Medical
GMED
|
18.2 M | $ 94.68 | 4.58 % | $ 12.9 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
1.56 B | $ 13.82 | 5.1 % | $ 1.06 B | ||
|
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | ||
|
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.21 | 1.6 % | $ 19.5 M | ||
|
IRadimed Corporation
IRMD
|
4.76 M | $ 99.94 | 1.63 % | $ 1.27 B | ||
|
Establishment Labs Holdings
ESTA
|
53.7 M | $ 72.94 | 4.19 % | $ 2.05 B | ||
|
Invacare Corporation
IVC
|
325 M | - | - | $ 24.7 M | ||
|
Cytosorbents Corporation
CTSO
|
14 M | $ 0.68 | -0.49 % | $ 37 M | ||
|
Integer Holdings Corporation
ITGR
|
1.02 B | $ 83.33 | 3.13 % | $ 2.8 B |